Literature DB >> 21839745

Conformational transformation and selection of synthetic prion strains.

Sina Ghaemmaghami1, Joel C Watts, Hoang-Oanh Nguyen, Shigenari Hayashi, Stephen J DeArmond, Stanley B Prusiner.   

Abstract

Prion protein is capable of folding into multiple self-replicating prion strains that produce phenotypically distinct neurological disorders. Although prion strains often breed true upon passage, they can also transform or "mutate" despite being devoid of nucleic acids. To dissect the mechanism of prion strain transformation, we studied the physicochemical evolution of a mouse synthetic prion (MoSP) strain, MoSP1, after repeated passage in mice and cultured cells. We show that MoSP1 gradually adopted shorter incubation times and lower conformational stabilities. These changes were accompanied by structural transformation, as indicated by a shift in the molecular mass of the protease-resistant core of MoSP1 from approximately 19 kDa [MoSP1(2)] to 21 kDa [MoSP1(1)]. We show that MoSP1(1) and MoSP1(2) can breed with fidelity when cloned in cells; however, when present as a mixture, MoSP1(1) preferentially proliferated, leading to the disappearance of MoSP1(2). In culture, the rate of this transformation process can be influenced by the composition of the culture media and the presence of polyamidoamines. Our findings demonstrate that prions can exist as a conformationally diverse population of strains, each capable of replicating with high fidelity. Rare conformational conversion, followed by competitive selection among the resulting pool of conformers, provides a mechanism for the adaptation of the prion population to its host environment.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21839745      PMCID: PMC3195964          DOI: 10.1016/j.jmb.2011.07.021

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  62 in total

1.  Cell division modulates prion accumulation in cultured cells.

Authors:  Sina Ghaemmaghami; Puay-Wah Phuan; Beth Perkins; Julie Ullman; Barnaby C H May; Fred E Cohen; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-07       Impact factor: 11.205

Review 2.  A general model of prion strains and their pathogenicity.

Authors:  John Collinge; Anthony R Clarke
Journal:  Science       Date:  2007-11-09       Impact factor: 47.728

3.  Eight prion strains have PrP(Sc) molecules with different conformations.

Authors:  J Safar; H Wille; V Itri; D Groth; H Serban; M Torchia; F E Cohen; S B Prusiner
Journal:  Nat Med       Date:  1998-10       Impact factor: 53.440

4.  Infectious prions in the saliva and blood of deer with chronic wasting disease.

Authors:  Candace K Mathiason; Jenny G Powers; Sallie J Dahmes; David A Osborn; Karl V Miller; Robert J Warren; Gary L Mason; Sheila A Hays; Jeanette Hayes-Klug; Davis M Seelig; Margaret A Wild; Lisa L Wolfe; Terry R Spraker; Michael W Miller; Christina J Sigurdson; Glenn C Telling; Edward A Hoover
Journal:  Science       Date:  2006-10-06       Impact factor: 47.728

5.  Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes.

Authors:  Giuseppe Legname; Hoang-Oanh B Nguyen; David Peretz; Fred E Cohen; Stephen J DeArmond; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-01       Impact factor: 11.205

6.  Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host.

Authors:  Melanie Meyer-Luehmann; Janaky Coomaraswamy; Tristan Bolmont; Stephan Kaeser; Claudia Schaefer; Ellen Kilger; Anton Neuenschwander; Dorothee Abramowski; Peter Frey; Anneliese L Jaton; Jean-Marie Vigouret; Paolo Paganetti; Dominic M Walsh; Paul M Mathews; Jorge Ghiso; Matthias Staufenbiel; Lary C Walker; Mathias Jucker
Journal:  Science       Date:  2006-09-22       Impact factor: 47.728

7.  Strain-specified characteristics of mouse synthetic prions.

Authors:  Giuseppe Legname; Hoang-Oanh B Nguyen; Ilia V Baskakov; Fred E Cohen; Stephen J Dearmond; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-25       Impact factor: 11.205

8.  Prion strain discrimination using luminescent conjugated polymers.

Authors:  Christina J Sigurdson; K Peter R Nilsson; Simone Hornemann; Giuseppe Manco; Magdalini Polymenidou; Petra Schwarz; Mario Leclerc; Per Hammarström; Kurt Wüthrich; Adriano Aguzzi
Journal:  Nat Methods       Date:  2007-11-18       Impact factor: 28.547

9.  Mapping the prion protein using recombinant antibodies.

Authors:  R A Williamson; D Peretz; C Pinilla; H Ball; R B Bastidas; R Rozenshteyn; R A Houghten; S B Prusiner; D R Burton
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

10.  Rapid and discriminatory diagnosis of scrapie and BSE in retro-pharyngeal lymph nodes of sheep.

Authors:  Jan P M Langeveld; Jorg G Jacobs; Jo H F Erkens; Alex Bossers; Fred G van Zijderveld; Lucien J M van Keulen
Journal:  BMC Vet Res       Date:  2006-06-09       Impact factor: 2.741

View more
  32 in total

1.  New Molecular Insight into Mechanism of Evolution of Mammalian Synthetic Prions.

Authors:  Natallia Makarava; Regina Savtchenko; Irina Alexeeva; Robert G Rohwer; Ilia V Baskakov
Journal:  Am J Pathol       Date:  2016-02-09       Impact factor: 4.307

2.  Changes in prion replication environment cause prion strain mutation.

Authors:  Nuria Gonzalez-Montalban; Young Jin Lee; Natallia Makarava; Regina Savtchenko; Ilia V Baskakov
Journal:  FASEB J       Date:  2013-05-31       Impact factor: 5.191

3.  Biaryl amides and hydrazones as therapeutics for prion disease in transgenic mice.

Authors:  Duo Lu; Kurt Giles; Zhe Li; Satish Rao; Elena Dolghih; Joel R Gever; Michal Geva; Manuel L Elepano; Abby Oehler; Clifford Bryant; Adam R Renslo; Matthew P Jacobson; Stephen J Dearmond; B Michael Silber; Stanley B Prusiner
Journal:  J Pharmacol Exp Ther       Date:  2013-08-21       Impact factor: 4.030

4.  A specific population of abnormal prion protein aggregates is preferentially taken up by cells and disaggregated in a strain-dependent manner.

Authors:  Young Pyo Choi; Suzette A Priola
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

5.  Atypical and classical forms of the disease-associated state of the prion protein exhibit distinct neuronal tropism, deposition patterns, and lesion profiles.

Authors:  Gabor G Kovacs; Natallia Makarava; Regina Savtchenko; Ilia V Baskakov
Journal:  Am J Pathol       Date:  2013-09-05       Impact factor: 4.307

Review 6.  Molecular Mechanisms of Chronic Wasting Disease Prion Propagation.

Authors:  Julie A Moreno; Glenn C Telling
Journal:  Cold Spring Harb Perspect Med       Date:  2018-06-01       Impact factor: 6.915

7.  Quinacrine treatment trial for sporadic Creutzfeldt-Jakob disease.

Authors:  Michael D Geschwind; Amy L Kuo; Katherine S Wong; Aissa Haman; Gillian Devereux; Benjamin J Raudabaugh; David Y Johnson; Charles C Torres-Chae; Ron Finley; Paul Garcia; Julie N Thai; Hugo Q Cheng; John M Neuhaus; Sven A Forner; Jacque L Duncan; Katherine L Possin; Stephen J Dearmond; Stanley B Prusiner; Bruce L Miller
Journal:  Neurology       Date:  2013-10-11       Impact factor: 9.910

8.  Drug resistance confounding prion therapeutics.

Authors:  David B Berry; Duo Lu; Michal Geva; Joel C Watts; Sumita Bhardwaj; Abby Oehler; Adam R Renslo; Stephen J DeArmond; Stanley B Prusiner; Kurt Giles
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-15       Impact factor: 11.205

9.  Convergent replication of mouse synthetic prion strains.

Authors:  Sina Ghaemmaghami; David W Colby; Hoang-Oanh B Nguyen; Shigenari Hayashi; Abby Oehler; Stephen J DeArmond; Stanley B Prusiner
Journal:  Am J Pathol       Date:  2013-03       Impact factor: 4.307

Review 10.  Biomolecular Assemblies: Moving from Observation to Predictive Design.

Authors:  Corey J Wilson; Andreas S Bommarius; Julie A Champion; Yury O Chernoff; David G Lynn; Anant K Paravastu; Chen Liang; Ming-Chien Hsieh; Jennifer M Heemstra
Journal:  Chem Rev       Date:  2018-10-03       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.